Automation index

How much of a Immunologist’s job can AI already do?

An autoantibody panel comes earlier. Calling it autoimmune without leaving the patient untreated do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#182 / 743

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#173 / 743

Cost engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Measure, rates and the budget. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Works, the variance and the one that was not logged. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Change, the extra and not giving it away. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Close, the dispute and not inflating. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Management, the bid and not selling the reckless one. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
The real number, and not the reckless bid. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low